Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Renal transplant recipients greater than 18 years of age, who have given written consent~Exclusion Criteria:~* Taking medications that may alter the metabolism of tacrolimus or mycophenolate sodium~* Experienced an acute rejection episode prior to the pharmacokinetic profile collection~* Serum creatinine \>2 mg/dL~* Neutropenia (Absolute Neutrophil Count \< 1.3x10\^3/mL)~* Received a previous transplant other than a kidney~* Receiving chronic steroids at time of transplant~* Known hypersensitivity to tacrolimus, mycophenolate mofetil, mycophenolate sodium, mycophenolic acid or any of its excipients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Myfortic - Fed State (Type: EXPERIMENTAL): Mycophenolate sodium taken with a meal.
- Myfortic - Fasting State (Type: EXPERIMENTAL): Mycophenolate sodium taken separately from food by 2 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).